Systems and methods for tibial plateau leveling osteotomy (TPLO) are disclosed. According to some embodiments, an osteotomy method may include cutting a tibia with an arcuate cut to separate a tibial plateau of the tibia from a tibial base of the tibia, rotating the tibial plateau relative to the tibial base from a first orientation to a second orientation, and, with the tibial plateau in the second orientation relative to the tibial base, securing an implant to the tibia to secure the tibial plateau to the tibial base. Securing the implant to the tibia may include embedding a first leg of the implant into the tibial base, and embedding a second leg of the implant into the tibial plateau such that the first and second legs apply compression urging the tibial plateau toward the tibial base.

Systems and methods for tibial plateau leveling osteotomy (TPLO) are disclosed. According to some embodiments, an osteotomy method may include cutting a tibia with an arcuate cut to separate a tibial plateau of the tibia from a tibial base of the tibia, rotating the tibial plateau relative to the tibial base from a first orientation to a second orientation, and, with the tibial plateau in the second orientation relative to the tibial base, securing an implant to the tibia to secure the tibial plateau to the tibial base. Securing the implant to the tibia may include embedding a first leg of the implant into the tibial base, and embedding a second leg of the implant into the tibial plateau such that the first and second legs apply compression urging the tibial plateau toward the tibial base.

Disclosed are methods, materials and devices for approximation of blood volume in a fluid, such as in a biological fluid collected during a surgical procedure. The method and devices include the use of a RBC flocculant, such as polyDADMAC, and an approximate blood hematocrit for the type of animal, as well as a calculated RBC packing ratio corresponding to the collection device being used. Also provided is a Blood Indicator Panel (BIP), comprising a series of markings calculated from an observed red blood settlement volume, the average animal type hematocrit, and a calculated RBC packing ratio “η” value for the collection device. Pediatric (about 200 ml or 250 ml size container), adult human (about 1,000 ml-1,500 ml) and veterinary (about 500 ml-2,500 ml) collection containers are also disclosed, that include a RBC flocculant, for use in approximating blood volume in a fluid.

Deep Tissue Low Intensity Laser Therapy or Treatment (DT-LILT) as described here is a novel methodology through which selective destruction of nociceptive (pain) nerves can be brought upon by a medical laser delivery system using the phenomenon of absorption and cell resonance. Using this method nerve cells that transmit pain can be selectively destroyed leaving the surrounding tissues intact as no heat is generated. The delivery system incorporates a fine needle through which a 703 nm (range 690 to 710) pulsed wave low intensity laser is delivered deep into the body, directly to the area of pain causing selective destruction of pain nerves. Laser devices based on this methodology should be used only by the physician or equivalent professional community since diagnosing and defining the area of pain is critical to providing successful pain relief.

Deep Tissue Low Intensity Laser Therapy or Treatment (DT-LILT) as described here is a novel methodology through which selective destruction of nociceptive (pain) nerves can be brought upon by a medical laser delivery system using the phenomenon of absorption and cell resonance. Using this method nerve cells that transmit pain can be selectively destroyed leaving the surrounding tissues intact as no heat is generated. The delivery system incorporates a fine needle through which a 703 nm (range 690 to 710) pulsed wave low intensity laser is delivered deep into the body, directly to the area of pain causing selective destruction of pain nerves. Laser devices based on this methodology should be used only by the physician or equivalent professional community since diagnosing and defining the area of pain is critical to providing successful pain relief.

The present invention relates to a single-use, disposable, tissue suspender device comprising a longitudinal body having a distal end and a proximal end, the thickness of the body being substantially constant along a major portion of the length of said body from said proximal end towards said distal end; wherein a region immediately preceding the distal end of the body presents a reduced thickness compared to the remainder of the longitudinal body extending back toward the proximal end; and wherein the distal end comprises a distal bar attached to the region of reduced thickness of the longitudinal body which adopts an unconstrained deviating angle to a longitudinal axis of the longitudinal body. The invention also relates to use of the device for suspending tissue in a human or animal body.

The present invention relates to a single-use, disposable, tissue suspender device comprising a longitudinal body having a distal end and a proximal end, the thickness of the body being substantially constant along a major portion of the length of said body from said proximal end towards said distal end; wherein a region immediately preceding the distal end of the body presents a reduced thickness compared to the remainder of the longitudinal body extending back toward the proximal end; and wherein the distal end comprises a distal bar attached to the region of reduced thickness of the longitudinal body which adopts an unconstrained deviating angle to a longitudinal axis of the longitudinal body. The invention also relates to use of the device for suspending tissue in a human or animal body.

A leech therapy device adapted to latch a medicinal leech to a predetermined wound site is provided. The leech therapy device incudes a conduit extending between a first end to a second end; an inner diameter of the conduit dimensioned to receive a medicinal leech, the inner diameter being less than twice a girth of the medicinal leech; and a cutout provided in the conduit closer to the first end than the second end; the cutout extending over a surface area between 100 and 150 squared millimeters. Wherein a user places a medicinal leech into the inner diameter, wherein a head of the medicinal leech is adjacent to the cutout, and then the user selectively positions said leech therapy device so that the cutout substantially circumscribed the wound site so that the medicinal leech can engage the wound site.

A hemostatic system includes a first tube defining a first lumen configured to channel a fluid therethrough, a second tube housing at least a portion of the first tube and at least partially defining a second lumen configured to channel a hemocoagulant agent therethrough, a hopper coupled to the second tube, and an injection device. The hopper defines a cavity in fluid communication with the second lumen and is configured to retain the hemocoagulant agent therein. The injection device is selectively positionable within the second lumen and/or the cavity to facilitate channeling the hemocoagulant agent from the cavity through the second lumen.

The invention relates to a process for the preparation of a rolled compressed collagen carrier and a process for un-rolling said rolled compressed collagen carrier. Said rolled compressed collagen carrier is ready for use in minimally invasive surgery. The invention also relates to a rolled compressed collagen carrier for use in the prevention or treatment of injury associated with performing minimally invasive surgery.